Seattle Genetics (SGEN) succeeded to reach their targeted goal in the clinical trials of a drug to treat blood cancer.
SGEN developed the drug brentuximab vedotin along with Japan’s Takeda Pharmaceutical. Researchers from the company Continue....
Category Archives: Cancer
Researchers found that the survival rate of patients having aggressive types of prostate cancer increased with the use of radical prostate surgery.
According to the study, which researchers presented at the American Urological Association Continue....
Researchers found that the trials of a drug for a type of breast cancer that is hard to treat showed great results.
Triple Negative Breast Cancer is a subtype of breast cancer that affects one out of seven women with the breast cancer. Continue....
A U.S. Food and Drug Agency (FDA) panel concluded favorable votes and said that the 3D Mammogram of Hologic showed potential in detecting breast tumors.
The federal agency raised 12-0 votes, with one member abstaining, to support the claims Continue....
An international consortium of scientists found five genetic variants that can be responsible for the development of ovarian cancer in women.
The study, posted in Nature Genetics journal, said that researchers found that there were Continue....
Two cancer walks for a cause launched
13-Sep-10Susan G. Komen Race for the Cure and Boston Marathon Jimmy Fund Walks commenced yesterday at Central Park West, New York, and Hopkinton, Massachusetts, respectively.
The two events wanted to raise fund for the research of cancer, education, Continue....
Health experts linked the increase colon cancer cases in the UK through being physically inactive and overweight.
Obesity and Lack of physical activities are the two factors that can affect highly in the increasing risk of colon cancer Continue....
A new approach in the treatment of prostate cancer has elevated its success rate and after-treatment benefits, staffs in Providence Hospital say.
The doctors and cancer specialists in the hospital had provided patients with prostate cancer Continue....
Ortho Biotech Oncology Research & Development’s abiraterone acetate showed effectiveness in the treatment of metastatic advanced prostate cancer.
Abiraterone acetate is undergoing clinical trials for efficiency and safety use. Continue....
Experts and cancer specialists encouraged 45 years old men especially who are at risk of prostate cancer to have annual screening.
According to other studies, people found to have BRCA genes mutations are more likely to develop cancer. Men Continue....